Tanvex BioPharma Names Stephen Lam as New CEO
Tanvex BioPharma Inc., a biosimilar-focused biopharmaceutical company and CDMO, has announced the appointment of Stephen Lam as its new Chief Executive Officer, effective September 5,…
Tanvex BioPharma Inc., a biosimilar-focused biopharmaceutical company and CDMO, has announced the appointment of Stephen Lam as its new Chief Executive Officer, effective September 5,…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.